Technology | Breast Imaging | November 16, 2015

First Non-Compression 3-D Breast CT Scanner Launched in the United States

Koning KBCT system enables faster detection and greater compliance for improved outcomes

Koning Corp., KBCT system, FDA approval, 3-D breast computed tomography, non-compression

KBCT system image courtesy of Koning Corp.

November 16, 2015 — Koning Corp. announced the first commercially available 3-D breast computed tomography (CT) scanner that overcomes the current limitations in 2-D diagnostic mammography. Koning’s technology, the Koning Breast Computed Tomography (KBCT) system, eliminates overlapping tissue concerns and addresses a common patient complaint – breast compression.

The KBCT was approved by the U.S. Food and Drug Administration (FDA) as a diagnostic device in February 2015 and is the first commercially available 3-D breast CT scanner designed specifically to image the entire breast with a single scan. Through the application of 360-degree multi-slice acquisition, breast tissue may be reviewed in multiple planes or in “genuine” 3-D reformation and at dose levels similar to diagnostic mammography. The system is designed to provide breast imaging specialists with the ability to view breast tissue with tools that have been in use for decades by CT body and neuro imagers.

The system offers several advantages to patients:

  • Image detail - Integrating conventional CT technology into this dedicated breast imaging device results in excellent spatial and contrast resolution in multiple planes. In addition, image information of the uncompressed breast produces a spatially representative mode, allowing accurate measurement of size, volume and density of breast tumors.
  • Comfortable prone positioning - Unlike upright conventional mammography, which requires specially trained technologists who use their skills to obtain an acceptable mammogram, KBCT image acquisition allows the patient to lie in a comfortable and natural prone position with minimal technologist manipulation of the breast tissue and without compression.

Other advantages from KBCT include 3-D targeting for minimally invasive breast biopsy (MIBB), and an alternative to magnetic resonance imaging (MRI) for neoadjuvant therapy monitoring and disease staging.

Approximately 1,000 patient scans on KBCT were conducted at Elizabeth Wende Breast Care, Rochester, New York, and the University of Rochester Medical Center. Additional collaboration at the UMass Memorial Medical Center, Worcester, Massachusetts, culminated in a large reader study conducted at the Medical University of South Carolina (MUSC) with Etta Pisano, M.D., a breast imaging expert, serving as the reader study principal investigator.

“I have been very impressed with the quality of the Koning images. It will be helpful to radiologists in identifying the true location of known lesions and providing diagnostic accuracy,” said Pisano. “I believe 3-D imaging will supplant 2-D imaging in the future.”

The KBCT technology will be displayed at the annual meeting of the Radiological Society of North America (RSNA), Nov. 29 – Dec. 4, 2015, in Chicago.

For more information:

Related Content

Sponsored Content | Videos | Artificial Intelligence | May 25, 2018
Change Healthcare is looking at how to apply AI into enterprise imaging by using algorhythms to change data into know
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
ACR Urges Stricter Adherence to Lung Cancer Screening Guidelines
News | Lung Cancer | May 21, 2018
A new statement from the American College of Radiology (ACR) asserts that provider non-compliance to lung cancer...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
FDA Clears CurveBeam LineUp Weight-Bearing Multi-Extremity CT System

Image courtesy of CurveBeam

Technology | Orthopedic Imaging | May 14, 2018
CurveBeam announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its LineUp Multi-...
Videos | Breast Imaging | May 08, 2018
ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central D
Overlay Init